Modeling Principle

The Lewis Rat Collagen Rheumatoid Arthritis Model (CIA model) is an internationally recognized SCI gold-standard classic animal model for the pathological mechanism analysis of rheumatoid arthritis (RA), regulation of synovial immune inflammation, research on osteochondral damage mechanisms, and preclinical efficacy evaluation of novel anti-RA drugs. Relying on the natural autoimmune genetic susceptibility of Lewis rats and their high sensitivity to type II collagen immune stimulation, the model specifically breaks local joint immune tolerance and systematically activates linked innate and adaptive immune responses through fractional subcutaneous injection of bovine type II collagen immune emulsion at the tail base, accurately recapitulating the typical clinical pathological phenotypes of human rheumatoid arthritis, including symmetric multi-joint swelling and redness, synovial hyperplasia and inflammation, pannus formation, cartilage degeneration, progressive bone erosion, and joint deformity and ankylosis. As a specific articular cartilage antigen, bovine type II collagen can be specifically recognized by host pattern recognition receptors, continuously activate the core TLR4/NF-κB inflammatory pathway, induce massive release of pro-inflammatory factors such as TNF-α, IL-6 and IL-1β, mediate abnormal proliferation of synovial fibroblasts, inflammatory cell infiltration and extensive neovascularization, gradually form typical pannus tissue, and continuously erode articular cartilage and bone tissue, completely reproducing the full-temporal disease progression of clinical RA from acute joint inflammation and subacute synovial hyperplasia to chronic irreversible bone destruction and joint function loss. Compared with CIA models established in SD and Wistar rats, the Lewis rat CIA model has core advantages of an extremely high modeling rate, strong symmetry of joint lesions, stable inflammatory timeline, severe bone damage, extremely low individual data dispersion and industry-leading reproducibility. With larger joint volume and more significant pathological changes, it is more suitable for refined mechanism verification and quantitative efficacy evaluation. The experimental paradigm fully complies with the specifications of high-impact SCI journals in rheumatology, osteoarticular surgery and anti-inflammatory translational medicine, and can be directly applied to National Natural Science Foundation projects, postgraduate research proposals and dissertations, serving as a standardized mainstream model for basic mechanism research of rheumatoid arthritis and screening of novel targeted anti-rheumatic drugs.

Modeling Success Criteria

Quantitative Joint Clinical Phenotype Criteria

Unified model evaluation is completed at the inflammatory peak of 28 d after modeling, and there are significant statistical differences between the model group, blank group and vehicle control group: 1. Joint phenotype: bilateral hind limb ankles, metatarsophalangeal and toe joints of rats present symmetric and persistent swelling and redness, joint bulging and increased skin temperature, with gradual joint stiffness and limited movement, without unilateral occasional lesions; 2. Behavioral and physical performance: rats show slowed or negative body weight growth, decreased activity, uneven limb weight bearing, abnormal gait and curling lethargy, without obvious eating disorders or severe exhaustion; 3. Quantitative scoring criteria: adopting the classic 5-grade arthritis scoring scale, the single limb score of the model group ≥ 2 points and the total four-limb cumulative score ≥ 6 points, with significantly higher joint swelling degree and joint circumference than the control groups and statistically significant inter-group differences; 4. Control validity: there is no significant difference in joint appearance, swelling degree and score between the vehicle control group and blank group, completely eliminating non-specific inflammatory interference caused by adjuvant, puncture and solvent; 5. Disease course stability: joint inflammation progresses continuously without spontaneous remission or invalid model individuals with stable and homogeneous symmetric inflammatory phenotypes. The Lewis rat collagen-induced rheumatoid arthritis model is successfully established when all the above quantitative joint phenotypic indicators reach the standard.

Histomorphometric Gold-Standard Indexes

Gold-standard histopathological evaluation of joint tissues: the ankle and metatarsophalangeal joints of rats in the model group present typical pathological changes of rheumatoid arthritis, including significant proliferation and thickening of synovial tissue, disordered layers, continuous massive infiltration of lymphocytes, macrophages and neutrophils, and abnormal proliferation and thickening of synovial lining cells; a large amount of inflammatory exudate accumulates in the joint cavity with intensive neovascularization, and typical pannus tissue forms and invades the joint space; a large amount of articular cartilage matrix is lost with thinning, disordered arrangement and surface wear and shedding of the cartilage layer and obvious degenerative damage; bone tissue presents RA-characteristic osseous damage such as sparse and disordered trabecular bone, enhanced bone resorption, local bone erosion and cortical bone damage. The blank group and vehicle control group have complete and well-structured joint synovium, cartilage and bone tissues without inflammatory infiltration, synovial hyperplasia or osteochondral damage. Core histomorphometric indexes: the synovial hyperplasia thickness, joint inflammatory infiltration grade, pannus neogenesis number, cartilage damage score and bone erosion area of the model group are significantly higher than those of the control groups. The pathological phenotype is completely consistent with the progressive damage characteristics of clinical rheumatoid arthritis: synovitis-pannus-osteochondral destruction, meeting the SCI gold standard for academic credibility.

Academic Evidence for Model Validity

The core academic validity basis of this model is as follows: relying on the autoimmune genetic susceptibility of Lewis rats, exogenous bovine type Ⅱ collagen antigen specifically activates the core RA inflammatory pathway of TLR4/NF-κB/TNF-α/IL-6, breaks local joint immune tolerance, induces abnormal synovial proliferation, persistent inflammatory infiltration, pannus formation and progressive osteochondral erosion, and accurately recapitulates the characteristic pathological mechanism and disease progression law of clinical RA: symmetric polyarthritis-chronic synovitis-irreversible bone destruction-joint function damage. This model has a clear modeling mechanism, stable inflammatory timeline, more typical symmetric lesions, prominent bone damage phenotype and extremely strong experimental reproducibility, which can accurately quantify and evaluate the regulatory and repair efficacy of various interventions on RA synovial inflammation, pannus hyperplasia, cartilage degeneration, bone erosion and systemic inflammatory disorders, serving as an authoritative SCI gold-standard model for chronic inflammatory mechanism research of rheumatoid arthritis and preclinical efficacy screening of anti-RA targeted drugs.

Model Advantages

The Lewis Rat Collagen Rheumatoid Arthritis Model is a high-impact SCI mainstream gold-standard model in the fields of rheumatoid arthritis chronic inflammation mechanism, synovial pannus regulation, osteochondral destruction mechanism and preclinical evaluation of novel anti-rheumatic drugs. Relying on the unique autoimmune genetic susceptibility of Lewis rats, it can stably and spontaneously form the complete RA pathological chain of limb symmetric polyarthritis-chronic synovitis-pannus hyperplasia-progressive bone erosion, perfectly recapitulating the chronic persistent and progressively aggravated disease characteristics of clinical RA and being significantly superior to mouse acute inflammation models. The modeling process is standardized with fixed immune timeline, simple operation, extremely low animal mortality and low ethical risks. It achieves a 95%–100% modeling rate with strong symmetry of joint lesions, high inflammatory homogeneity, minimal individual differences, persistent and stable disease course and industry-leading data reproducibility. It precisely targets the classic TLR4/NF-κB/TNF-α inflammatory pathogenic pathway of RA with highly clinically consistent pathological mechanisms. Rat joints are larger in size, more suitable for fine pathological sampling, Micro-CT quantitative analysis and local molecular detection with higher experimental data accuracy. It adapts to multi-dimensional closed-loop verification including joint appearance, functional scoring, histopathology, bone microstructure and molecular pathways. The experimental data is highly recognized and easily accepted by authoritative SCI journals in rheumatology, osteoarticular surgery and anti-inflammatory translational medicine, fully adapting to the high-level scientific research system of National Natural Science Foundation projects, fund application, research proposals and postgraduate dissertations.

Research Applications

This model is mainly used to systematically elucidate the core molecular mechanisms of collagen-mediated TLR4/NF-κB pathway activation, TNF-α/IL-6 inflammatory storm, abnormal synovial proliferation, pannus formation and osteochondral erosion. It accurately evaluates the dual anti-inflammatory and bone-protective efficacy of traditional Chinese medicine compounds, natural active ingredients, chemically synthesized drugs, targeted preparations and biomaterials on rheumatoid arthritis joint inflammation, synovial hyperplasia, pannus formation and bone destruction. It verifies the progressive linked pathogenic mechanism of immune sensitization-synovial inflammation-pannus invasion-bone metabolism imbalance and explores novel anti-inflammatory, anti-synovial and bone-protective immune intervention targets and signaling pathways for rheumatoid arthritis, optimizing the collaborative treatment scheme for early inflammatory intervention and advanced bone damage repair of RA. It is widely applied in full scientific research scenarios including basic mechanism research of rheumatoid arthritis, preclinical efficacy screening of new anti-RA drugs, osteoarticular inflammation translational medicine research, fund project application, research proposal writing and high-impact SCI paper publication, serving as one of the standardized SCI gold-standard animal models with the highest clinical consistency and optimal reproducibility in the current RA research field.

Lewis rat, collagen-induced rheumatoid arthritis, CIA model, symmetric polyarthritis, joint synovitis, pannus hyperplasia, osteochondral erosion, TNF-α/IL-6 inflammatory axis, rheumatoid arthritis animal model, anti-rheumatic drug screening